Cancer-induced Expansion and Activation of CD11b+Gr-1+ Cells Predispose Mice to Adenoviral-triggered Anaphylactoid-type Reactions
Open Access
- 1 March 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (3) , 508-515
- https://doi.org/10.1038/mt.2008.280
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisCancer Cell, 2008
- Anaphylaxis: Lessons from mouse modelsJournal of Allergy and Clinical Immunology, 2007
- Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cellsJournal of Clinical Investigation, 2006
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 2006
- Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyesAnnals of Allergy, Asthma & Immunology, 2006
- Allergic-type reactions to oxaliplatin: Retrospective analysis of 42 patientsEuropean Journal Of Cancer, 2005
- Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular ResponsesMolecular Therapy, 2005
- Severe pulmonary pathology after intravenous administration of vectors in cirrhotic ratsMolecular Therapy, 2004
- A Hemodynamic Response to Intravenous Adenovirus Vector Particles Is Caused by Systemic Kupffer Cell-Mediated Activation of Endothelial CellsHuman Gene Therapy, 2003
- Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy, 2002